Limit on cold remedies for kids was FDA's idea

AP - When drug makers made a surprise announcement this week that they no longer recommend cough and cold remedies for youngsters under 4, they didn't let on that it was the government's idea.

Stem cell generation from ordinary cells now safe

Reuters - Japanese researchers who invented a way to make powerful stem cells out of ordinary cells say they have now found a safer way to do it.

Home hemodialysis cuts hospital days

Reuters - The number of hospital days is lower for daily home hemodialysis patients than for peritoneal dialysis patients, according to a report in the American Journal of Kidney Diseases.

HPV infection rates similar in men and women

Reuters - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.

Lung cancer in non-smokers a separate disease

Naps don't harm older folks' nighttime sleep

Reuters - In older adults, taking naps during the day, even in the late afternoon or early evening, does not seem to detract from hours of sleep logged at night or the quality of that sleep, research suggests.

Occupational injuries very common in surgeons

Latex hides in unexpected places, experts warn

Reuters - Inadvertent exposure to latex poses a "serious health risk to millions of Americans," Dr. Donald H. Beezhold, chair of the Latex Allergy Committee of the American Academy of Allergy, Asthma & Immunology (AAAAI) warns in a statement issued this month.

Infliximab-Based Treatment Effective for Crohn's Patients

HealthDay - THURSDAY, Oct. 9 (HealthDay News) -- Infliximab (Remicade) alone or in combination with azathioprine is more effective in treating Crohn's disease than azathioprine alone, researchers report.